Unknown

Dataset Information

Endocrine-Resistant Breast Cancer: Mechanisms and Treatment.


ABSTRACT:

Background

Endocrine treatment is one of the most effective therapies for estrogen receptor-positive breast cancer. However, most tumors will develop resistance to endocrine therapy as the cancer progresses. This review focuses on the mechanisms and markers of endocrine-resistant breast cancer. In addition, current and future strategies to overcome endocrine resistance are discussed.

Summary

Several molecular mechanisms of endocrine resistance have been identified, including alterations in the ESR1 gene or in the PIK3CA/mTOR pathway. Meanwhile, CDK4/6, mTOR, and PI3K inhibition have shown to improve the efficacy of endocrine treatment and new promising approaches are being developed.

Key message

Overcoming primary or acquired resistance to endocrine treatment remains

SUBMITTER: Hartkopf AD 

PROVIDER: S-EPMC7490658 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature